latest news releases from the newsroom
Samaritan Pharmaceuticals, Inc.
Samaritan to Highlight Its Novel Alzheimer's Drug Caprospinol (SP-233) At BIO International Convention 2007
LAS VEGAS, May 1, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today, it will present its late-stage preclinical drug candidates at the BIO International Convention 2007 in Boston, MA, on May 8, 2007 at 3 PM EDT, Room D, in the Business Forum. Samaritan will highlight its novel Alzheimer's drug, Caprospinol (SP-233) as the closest to potentially enter Phase I human clinical trials, as well as present its acute coronary drug candidate (SP-1000) and its oral hepatitis C drug candidate (SP-10T1).
Alfa International Engages Hamdan as Strategic Consultant
NEW YORK, May 1, 2007 (PRIME NEWSWIRE) -- In its annual report on Form 10-KSB for the year ended December 31, 2006, filed with the SEC ("10K"), Alfa International Holdings Corp. (OTCBB:AHDS) announced that it has engaged the services of Sam Hamdan as its chief strategic consultant.
MEDirect Latino, Inc.
MEDirect Latino Inc. Licensed to Provide Products and Services to the Kansas Medicaid Program
POMPANO BEACH, Fla., May 1, 2007 (PRIME NEWSWIRE) -- MEDirect Latino Inc. (Pink Sheets:MLTO) (www.medirectlatino.org), the first national provider of direct-to-consumer Medicare reimbursed medical products focused exclusively on chronic diseases afflicting the Hispanic community, today announced that the Company has been issued a Medicaid Provider License by the State of Kansas Department of Social and Rehabilitation Services, and will immediately begin servicing the state's Medicaid beneficiaries.